Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

News Spotlights Stocks

Nestle misses nine-month sales estimates, expects volume upturn by year-end

post-img

(Reuters) – Nestle posted lower-than-expected nine-month sales growth on Thursday as higher product prices made shoppers balk, sending shares down about 2% in morning trade, but said it expects volumes to turn positive again by the end of the year.

The packaged goods industry has for over two years hit shoppers with higher prices, citing higher input costs that started with the COVID-19 pandemic and were exacerbated by Russia’s invasion of Ukraine. Everything from sunflower oil to freight has become more expensive, taking a toll on global supply chains.

Nestle’s 8.4% price increase was below the average analyst estimate of 8.6%. Real internal growth (RIG) – or a measure of sales volumes – fell 0.6%, meeting expectations. In the third quarter, RIG improved to a decline of 0.3%, Nestle said.

The company’s CEO, Mark Schneider, said he had “confidence that real internal growth, the sum of volume and mix, will turn positive in the second half of the year and again become the main driver of growth going forward.”

“Pricing will be more targeted, by brand and by country,” Schneider said.

P&G, which makes Tide detergent and Gillette razors, on Wednesday reported weak sales volumes, but said this was stabilising and would start to pick up through the rest of the year.

“The (Nestle) results were slightly underwhelming. The market was expecting more on volumes,” Aviva (LON:AV) portfolio manager Richard Saldanha said. “The ultimate catalyst for the stock’s multiple to improve is going to be seeing that volume number going positive.”

“Pricing has moderated so we should see some sign of volume improvement soon…there are clearly some categories that remain quite challenged like water and health sciences.”

Investors and analysts have raised concerns that companies are pushing price rises too far and recommended that they focus more on marketing and innovation, amid a cost of living crisis that is seeing retailers’ private label brands stealing market share.

Organic sales, which exclude the impact of currency movement and acquisitions, rose 7.8% in the nine months ended September, the maker of Maggi stock cubes and Nescafe coffee said.

Analysts had on average expected organic sales growth of 8.1%.

Executives have in recent quarters flagged that costs are rising at a slower pace, but also warned that shoppers would continue to pay more for products like soap, toilet paper and coffee because companies still have not recouped years of damage from higher expenses.

Nestle confirmed its full-year outlook of organic sales growth between 7% and 8% and underlying trading operating profit margin between 17.0% and 17.5%.

A Nestle spokesperson said the firm had “not seen any impact from (weight loss drugs) on our sales”, referring to the potential threat posed to the packaged food industry by Novo Nordisk (NYSE:NVO)’s blockbuster weight-loss drug Wegovy.

The drug’s popularity has prompted concerns in the consumer and retail industry over whether food sales will be impacted. Nestle shares fell this month after Walmart (NYSE:WMT), the world’s biggest retailer, said that it saw a slight pullback in food consumption with people taking appetite-suppressing drugs like Wegovy.

($1 = 0.8989 Swiss francs)

Related Post